Tymecka, M.; Hac-Wydro, K.; Obloza, M.; Bonarek, P.; Kaminski, K.
The Use of a Barley-Based Well to Define Cationic Betaglucan to Study Mammalian Cell Toxicity Associated with Interactions with Biological Structures. Pharmaceutics 2023, 15, 2009.
https://doi.org/10.3390/pharmaceutics15072009
AMA Style
Tymecka M, Hac-Wydro K, Obloza M, Bonarek P, Kaminski K.
The Use of a Barley-Based Well to Define Cationic Betaglucan to Study Mammalian Cell Toxicity Associated with Interactions with Biological Structures. Pharmaceutics. 2023; 15(7):2009.
https://doi.org/10.3390/pharmaceutics15072009
Chicago/Turabian Style
Tymecka, Malgorzata, Katarzyna Hac-Wydro, Magdalena Obloza, Piotr Bonarek, and Kamil Kaminski.
2023. "The Use of a Barley-Based Well to Define Cationic Betaglucan to Study Mammalian Cell Toxicity Associated with Interactions with Biological Structures" Pharmaceutics 15, no. 7: 2009.
https://doi.org/10.3390/pharmaceutics15072009
APA Style
Tymecka, M., Hac-Wydro, K., Obloza, M., Bonarek, P., & Kaminski, K.
(2023). The Use of a Barley-Based Well to Define Cationic Betaglucan to Study Mammalian Cell Toxicity Associated with Interactions with Biological Structures. Pharmaceutics, 15(7), 2009.
https://doi.org/10.3390/pharmaceutics15072009